Further evidence has emerged to support intensive treatment of hypertension, with a study showing a systolic blood-pressure target of 110 – 130 mm Hg results in a lower incidence of cardiovascular events than standard treatment to a target of 130 – 150 mm Hg. In the Chinese STEP trial, 8,511 patients 60 to 80 years ...
Go lower: new evidence beyond SPRINT supports case for intensive BP control
By Mardi Chapman
7 Oct 2021